Wide-Ranging Longevity Benefits Of PycnogenolJune 2014
By Sarah Brighton
Pycnogenol Offers Neuroprotection
Human studies have not yet been conducted, but exciting basic science is being done in laboratories around the world on the potential for Pycnogenol to improve some of the most heartbreaking diseases of aging, the neurodegenerative conditions that include Alzheimer’s and Parkinson’s diseases. Studies are showing that Pycnogenol’s powerful antioxidant properties can intercept ongoing oxidant damage that leads to these disorders.
Studies reveal sharp drops in markers of both oxidation and inflammation when Pycnogenol is provided in animal models of Alzheimer’s and Parkinson’s diseases, as well as of diabetes, which is a leading cause of neurodegeneration.31-33 Pycnogenol protects brain cells and their supporting structures from premature cell death, and mitigates the decline in cognitive performance seen in an animal model of Alzheimer’s.31,33,34 Pycnogenol also boosts brain cells’ own natural cellular antioxidant systems, helping them resist chronic damage.35
Pycnogenol, a standardized mixture of pine bark-derived flavonoids, has long been used in Europe to treat cardiovascular disease, metabolic syndrome, diabetes, and neurodegenerative conditions.
Emerging research reveals that Pycnogenol is valuable in skin inflammation, the management of pain, traumatic brain injury, and tinnitus.36-40
It’s regrettable that so few physicians in the United States recommend Pycnogenol considering its clinical utility has been demonstrated in over 300 scientific publications.
If you have any questions on the scientific content of this article, please call a Life Extension® Health Advisor at 1-866-864-3027.
- Packer L, Rimbach G, Virgili F. Antioxidant activity and biologic properties of a procyanidin-rich extract from pine (Pinus maritima) bark, Pycnogenol. Free Radic Biol Med. 1999 Sep;27(5-6):704-24.
- Masoudi FA, Ponirakis A, et al. Cardiovascular care facts: a report from the national cardiovascular data registry: 2011. J Am Coll Cardiol. 2013 Nov 19;62(21):1931-47.
- Su JJ, Park SK, Hsieh TM. The effect of testosterone on cardiovascular disease: a critical review of the literature. Am J Mens Health. 2014 Feb 20.
- Enseleit F, Sudano I, Periat D, et al. Effects of Pycnogenol on endothelial function in patients with stable coronary artery disease: a double-blind, randomized, placebo-controlled, cross-over study. Eur Heart J. 2012 Jul;33(13):1589-97.
- Belcaro G, Dugall M, Hosoi M, et al. Pycnogenol(R) and Centella Asiatica for asymptomatic atherosclerosis progression. Int Angiol. 2014 Feb;33(1):20-6.
- Belcaro G, Cesarone MR, Dugall M, et al. Investigation of Pycnogenol in combination with coenzymeQ10 in heart failure patients (NYHA II/III). Panminerva Med. 2010 Jun;52(2 Suppl 1):21-5.
- Tedgui A, Mallat Z. Atherosclerotic plaque formation. Rev Prat. 1999 Dec 1;49(19):2081-6.
- Stocker R, Keaney JF Jr. Role of oxidative modifications in atherosclerosis. Physiol Rev. 2004 Oct;84(4):1381-478.
- Chi Z, Melendez AJ. Role of cell adhesion molecules and immune-cell migration in the initiation, onset and development of atherosclerosis. Cell Adh Migr. 2007 Oct-Dec;1(4):171-5.
- Hunt BJ. The endothelium in atherogenesis. Lupus. 2000;9(3):189-93.
- Crowther MA. Pathogenesis of atherosclerosis. Hematology Am Soc Hematol Educ Program. 2005:436-41.
- Fitzpatrick DF, Bing B, Rohdewald P. Endothelium-dependent vascular effects of Pycnogenol. J Cardiovasc Pharmacol. 1998 Oct;32(4):509-15.
- Rezzani R, Porteri E, De Ciuceis C, et al. Effects of melatonin and Pycnogenol on small artery structure and function in spontaneously hypertensive rats. Hypertension. 2010 Jun;55(6):1373-80.
- Peng Q, Wei Z, Lau BH. Pycnogenol inhibits tumor necrosis factor-alpha-induced nuclear factor kappa B activation and adhesion molecule expression in human vascular endothelial cells. Cell Mol Life Sci. 2000 May;57(5):834-41.
- Available at: http://nar.oxfordjournals.org/content/33/16/5308.full. Accessed March 20, 2014.
- Samson SL, Garber AJ. Metabolic Syndrome. Endocrinol Metab Clin North Am. 2014 Mar;43(1):1-23.
- Extermann M. Metabolic syndrome, aging, and cancer. Crit Rev Oncog. 2013;18(6):515-29.
- Holvoet P. Relations between metabolic syndrome, oxidative stress and inflammation and cardiovascular disease. Verh K Acad Geneeskd Belg. 2008;70(3):193-219.
- Available at: http://www.jci.org/articles/view/21625. Accessed March 20, 2014.
- Belcaro G, Cornelli U, Luzzi R, et al. Pycnogenol(R) supplementation improves health risk factors in subjects with metabolic syndrome. Phytother Res. 2013 Oct;27(10):1572-8.
- Stuard S, Belcaro G, Cesarone MR, et al. Kidney function in metabolic syndrome may be improved with Pycnogenol(R). Panminerva Med. 2010 Jun;52(2 Suppl 1):27-32.
- Liu X, Wei J, Tan F, Zhou S, Wurthwein G, Rohdewald P. Antidiabetic effect of Pycnogenol French maritime pine bark extract in patients with diabetes type II. Life Sci. 2004 Oct 8;75(21):2505-13.
- Cesarone MR, Belcaro G, Rohdewald P, et al. Improvement of diabetic microangiopathy with pycnogenol: A prospective, controlled study. Angiology. 2006 Aug-Sep;57(4):431-6.
- Jankyova S, Kucera P, Goldenberg Z, et al. Pycnogenol efficiency on glycaemia, motor nerve conduction velocity and markers of oxidative stress in mild type diabetes in rats. Phytother Res. 2009 Aug;23(8):1169-74.
- Kolacek M, Muchova J, Vrankova S, et al. Effect of natural polyphenols, pycnogenol(R) on superoxide dismutase and nitric oxide synthase in diabetic rats. Prague Med Rep. 2010;111(4):279-88.
- Maritim A, Dene BA, Sanders RA, Watkins JB, 3rd. Effects of pycnogenol treatment on oxidative stress in streptozotocin-induced diabetic rats. J Biochem Mol Toxicol. 2003;17(3):193-9.
- Parveen K, Khan MR, Mujeeb M, Siddiqui WA. Protective effects of Pycnogenol on hyperglycemia-induced oxidative damage in the liver of type 2 diabetic rats. Chem Biol Interact. 2010 Jul 30;186(2):219-27.
- Nocun M, Ulicna O, Muchova J, Durackova Z, Watala C. French maritime pine bark extract Pycnogenol reduces thromboxane generation in blood from diabetic male rats. Biomed Pharmacother. 2008 Mar;62(3):168-72.
- Schafer A, Hogger P. Oligomeric procyanidins of French maritime pine bark extract (Pycnogenol) effectively inhibit alpha-glucosidase. Diabetes Res Clin Pract. 2007 Jul;77(1):41-6.
- Jo SH , Ha KS, Moon KS, et al. Molecular weight dependent glucose lowering effect of low molecular weight chitosan oligosaccharide (GO2KA1) on postprandial blood glucose level in SD rats model. Int J Mol Sci. 2013 Jul 9;14(7):14214-24. doi: 10.3390/ijms140714214.
- Ishrat T, Parveen K, Hoda MN, et al. Effects of Pycnogenol and vitamin E on cognitive deficits and oxidative damage induced by intracerebroventricular streptozotocin in rats. Behav Pharmacol. 2009 Oct;20(7):567-75.
- Liu F, Lau BH, Peng Q, Shah V. Pycnogenol protects vascular endothelial cells from beta-amyloid-induced injury. Biol Pharm Bull. 2000 Jun;23(6):735-7.
- Khan MM, Kempuraj D, Thangavel R, Zaheer A. Protection of MPTP-induced neuroinflammation and neurodegeneration by Pycnogenol. Neurochem Int. 2013 Mar;62(4):379-88.
- Peng QL, Buz’Zard AR, Lau BH. Pycnogenol protects neurons from amyloid-beta peptide-induced apoptosis. Brain Res Mol Brain Res. 2002 Jul 15;104(1):55-65.
- Ansari MA, Keller JN, Scheff SW. Protective effect of Pycnogenol in human neuroblastoma SH-SY5Y cells following acrolein-induced cytotoxicity. Free Radic Biol Med. 2008 Dec 1;45(11):1510-9.
- Sime, Reeve VE. Protection from inflammation, immunosuppression and carcinogenesis induced by UV radiation in mice by topical Pycnogenol. Photochem Photobiol. 2004 Feb;79(2):193-8.
- Marini A, Grether-Beck S, Jaenicke T, et al. Pycnogenol(R) effects on skin elasticity and hydration coincide with increased gene expressions of collagen type I and hyaluronic acid synthase in women. Skin Pharmacol Physiol. 2012;25(2):86-92.
- Vinciguerra G, Belcaro G, Cesarone MR, et al. Cramps and muscular pain: prevention with pycnogenol in normal subjects, venous patients, athletes, claudicants and in diabetic microangiopathy. Angiology. 2006 May-Jun;57(3):331-9.
- Maia H, Jr., Haddad C, Casoy J. Combining oral contraceptives with a natural nuclear factor-kappa B inhibitor for the treatment of endometriosis-related pain. Int J Womens Health. 2013;6:35-9.
- Scheff SW, Ansari MA, Roberts KN. Neuroprotective effect of Pycnogenol(R) following traumatic brain injury. Exp Neurol. 2013 Jan;239:183-91.
- Ansari MA, Roberts KN, Scheff SW. Dose- and time-dependent neuroprotective effects of Pycnogenol following traumatic brain injury. J Neurotrauma. 2013 Sep 1;30(17):1542-9.
- Neri S, Signorelli S, Pulvirenti D, et al. Oxidative stress, nitric oxide, endothelial dysfunction and tinnitus. Free Radic Res. 2006 Jun;40(6):615-8.
- Baguley D1, McFerran D, Hall D. Tinnitus. Lancet. 2013 Nov 9;382(9904):1600-7
- MG, Belcaro G, Cesarone MR, et al. Improvement in cochlear flow with Pycnogenol(R) in patients with tinnitus: a pilot evaluation. Panminerva Med. 2010 Jun;52(2 Suppl 1):63-7.